Occult cancer and unprovoked venous thromboembolism: What’s their relationship?
Occult cancers are generally advanced or metastatic tumors with unknown primary origin. In some cases, they are...
Most Read
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
An interview with Dr. Alok Khorana
We met with Dr. Alok Khorana in Berlin during the ISTH 2017 Congress. He could not hide his enthusiasm about the...
ISTH 2019: The CAT treatment, from trials to clinical practice
Straight from ISTH 2019 Alok Khorana tells us what’s new in the CAT...
Prophylaxis for venous thromboembolism in COVID-19 Patients
The development of venous thromboembolism (VTE) is one of the major consequences observed in patients with Coronavirus...
Registration for the EHA-SWG Pediatric meeting is now open!
EHA-SWG Scientific Meeting ”The Blood and the Child – New Insights in Pediatric Benign Hematology”...
KRAS-activating mutations: an independent risk factor for VTE?
Colorectal cancer (CRC) is the third most common type of cancer in Europe , after breast and prostate cancer, and...
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
The authors of a recent study1 have taken a novel look at the impact of venous thromboembolism (VTE) among...
Platelet-educated cancer cells and tumor-educated platelets: an egg-and-chicken debate
Platelets are versatile cells with known functions in hemostasis, thrombosis, inflammation, and several pathological...
Management and safety considerations in specific sub-populations of patients with cancer
During the ICTHIC webinar “CAT management: challenges in different cancer populations”, Prof Walter Ageno gave a...